| SMMT Stock | | | USD 17.77 0.72 3.89% |
Summit Therapeutics financial indicator trend analysis is much more than just breaking down Summit Therapeutics PLC prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Summit Therapeutics PLC is a good investment. Please check the relationship between Summit Therapeutics Total Current Liabilities and its Property Plant And Equipment Net accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Summit Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
Total Current Liabilities vs Property Plant And Equipment Net
Total Current Liabilities vs Property Plant And Equipment Net Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Summit Therapeutics PLC Total Current Liabilities account and
Property Plant And Equipment Net. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Summit Therapeutics' Total Current Liabilities and Property Plant And Equipment Net is 0.59. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Summit Therapeutics PLC, assuming nothing else is changed. The correlation between historical values of Summit Therapeutics' Total Current Liabilities and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Summit Therapeutics PLC are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Total Current Liabilities i.e., Summit Therapeutics' Total Current Liabilities and Property Plant And Equipment Net go up and down completely randomly.
Correlation Coefficient | 0.59 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Total Current Liabilities
Total Current Liabilities is an item on Summit Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Summit Therapeutics PLC are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from Summit Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Summit Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Summit Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
At this time, Summit Therapeutics'
Selling General Administrative is comparatively stable compared to the past year.
Sales General And Administrative To Revenue is likely to gain to 35.83 in 2024, whereas
Tax Provision is likely to drop (25.4
K) in 2024.
Summit Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Summit Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Summit Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to
measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.